Compounded semaglutide cost: the real number

Advertised prices commonly run about $149 to $299 a month, with a broader range of roughly $99 to $349 depending on the provider, dose, and whether it's bundled with a visit. But those headline "starting" prices often exclude the consult fee, lab work, and higher-dose pricing — so the real out-of-pocket frequently lands at $250 a month or more. Always ask for the total monthly cost including the visit, not just the medication's advertised starting price.

Compounded semaglutide skips the FDA approval process, brand development, and large-scale manufacturing overhead, which is why the advertised price is far below brand list prices. But that discount comes with real trade-offs: compounded products are not FDA-approved, their strength and purity are not FDA-verified, and the compounded version was never studied in clinical trials. The lower price reflects less oversight, not just efficiency.

Much less than before. The FDA declared the semaglutide shortage resolved in February 2025, and the enforcement grace periods that let pharmacies compound it widely ended in 2025. So the era of freely available, low-cost compounded semaglutide has largely ended — compounding can still be legitimate in narrow, individualized situations (a documented clinical need), but not as a mass-market copy. A site still selling cheap compounded semaglutide with no questions asked is a reason for more caution, not less.

The advertised monthly price is often just the lowest starting dose and may not include: the telehealth consultation fee, required lab work, the cost of higher maintenance doses (which usually cost more), shipping, and any membership or program fee. Some "$149/month" offers become $250–$350 once everything is added. Ask each provider for the all-in monthly cost at your target dose, and compare that number — not the headline.

Price isn't the safety issue — oversight is. Because compounded semaglutide isn't FDA-approved, its quality depends entirely on the pharmacy. The FDA has flagged concerns including non-approved salt forms (semaglutide sodium/acetate) and dosing errors. If you consider it, use a reputable pharmacy (ideally a 503B outsourcing facility), confirm it's base semaglutide, insist on clear dosing, and never buy without a prescription. The FDA-approved options remain the only versions actually tested. See our compounded safety guide.

Less than the headlines suggest. Compounded semaglutide advertises around $69–$300/mo, but that is usually the starting dose, medication only — add consult, labs and higher-dose pricing and the real figure climbs. Meanwhile the brand cash programs came down: Wegovy runs about $349/month at maintenance (with a $199 introductory price), and the oral Wegovy pill starts around $149. Compare all-in totals at your target dose — one of those options is FDA-approved and one is not.

Almost never. Insurers generally do not cover compounded drugs, and FSA/HSA reimbursement varies by administrator. That means the cash price is the whole price — there is no copay to fall back on and no appeal route if the cost rises. By contrast, a denied brand prescription can be appealed, and an approved one can drop to a copay. Before choosing the compounded path on cost alone, it is worth finding out what your plan would actually charge for the approved product.

Be careful. Prepaid multi-month plans move the program's risk onto you: GLP-1 discontinuation is common, mostly from gastrointestinal side effects during titration, and a person who stops in month two has paid for four months they will not use. Ask the refund policy in writing before prepaying. A slightly higher month-to-month price with a clean exit is often the better deal in practice.